Ping An Haoyi Medical Laboratory Establishes Guangzhou Facility Through Sino-Japanese Collaboration to Advance National Tiered Diagnosis and Treatment Policy

VCBeat has learned that the “China-Japan Summit on Medical Laboratory Medicine,” themed “Precision, Efficiency, and Win-Win Cooperation,” along with the grand opening ceremony of the Guangzhou Ping An Haoyi Medical Laboratory (hereinafter referred to as the “Guangzhou Laboratory Center”), was recently held.

Hao Deming, Vice President and Secretary-General of the Chinese Non-Public Medical Institutions Association; Hideki Ishizuka, Consul General of Japan in Guangzhou; Luo Daxiang, Executive Deputy Director of the Office of the Leading Group for Promoting the Construction of the Guangdong-Hong Kong-Macao Greater Bay Area in Guangzhou Development District; Liao Xinbo, former Deputy Director of the Guangdong Provincial Department of Health; Jiang Ying, General Manager of Ping An Health (Testing) Center; Naoyoshi Kubota, President and CEO of SRL International Co., Ltd. (Japan); Han Kun, Director of the Chinese Journal of Laboratory Medicine; Zou Weimin, Director of the Guangdong Provincial Clinical Laboratory Center; Professor Xia Yong, Chairman of the Laboratory Medicine Branch of the Guangzhou Medical Association; and other representatives from government departments, industry associations, media outlets, and Ping An Group’s affiliated entities in Guangdong attended the event.

At the conference, Jiang Ying first expressed sincere gratitude on behalf of Ping An Health (Testing) Center to all sectors of society for their care and support. She stated that, under the policy calls from the Party and the state to support privately-run medical institutions and develop the health industry, Ping An Health (Testing) Center pioneered in China an innovative “trinity” medical model integrating imaging diagnosis, medical laboratory testing, and precision examinations, with medical laboratory testing serving as the core component of this innovative business format.

Jiang Ying, General Manager of Ping An Health (Screening) Center

Ping An Health (Testing) Center and SRL, a subsidiary of Japan’s Miraca Group—a world-leading medical laboratory service provider—jointly invested in establishing the Ping An Haoyi Medical Laboratory. Leveraging the Chinese partner’s strong financial strength, extensive customer base, robust marketing network, leading R&D capabilities, and highly influential brand value, as well as the Japanese partner’s world-class quality control standards, comprehensive test menu, efficient automated processes, and cost advantages, the laboratory operates on the principle of “Japanese technology, Chinese pricing” to benefit the general public in China.

Hideki Ishizuka, Consul-General of Japan in Guangzhou, stated that as China continues to encourage the opening and development of the medical testing market, demand for world-class clinical laboratory services is growing. Leveraging its more than 50 years of expertise and industry experience in clinical laboratory testing, SRL has established a joint venture with Ping An to provide better healthcare services to the Chinese public. The success of this initiative will not only contribute to the advancement of healthcare in both China and Japan but also promote the building of new China-Japan economic cooperation.

Consul-General of the Consulate-General of Japan in Guangzhou, Hideki Ishizuka

Currently, Ping An Health (Testing) Center has established provincial-level medical testing laboratories in Guangzhou, Wuhan, Hefei, Hangzhou, and other cities. It will further expand its nationwide footprint to Beijing, Shanghai, Chengdu, Nanchang, Shenyang, and other locations, committed to promoting the precise, efficient, and rapid development of the third-party medical testing industry.

At the China-Japan Summit on Laboratory Medicine, themed “Precision, Efficiency, and Win-Win Collaboration,” Japanese experts from SRL joined chair-level experts from the Guangzhou Medical Laboratory Association and national medical laboratory associations in a roundtable discussion. They focused on current hot topics such as “Building Laboratory Medical Consortia under the New Landscape of Healthcare Reform” and “Co-construction and Mutual Benefit of Regional Laboratory Centers,” jointly exploring the future development path of China’s clinical laboratory industry. 

China-Japan Summit Forum on Medical Laboratory Science

The Chinese government has successively introduced policies to establish a diversified healthcare delivery system characterized by “public medical institutions as the mainstay, with non-public medical sectors developing in synergy.” Meanwhile, the governments of China and Japan have reached a consensus on “jointly carrying out third-party cooperation and jointly exploring third-party markets.”

In this context, Ping An Group has positioned big health and medical care as one of its core strategies, making significant contributions to the development of China’s non-public healthcare system. The collaboration between Ping An Health (Testing) Center and Japan’s SRL Corporation exemplifies Ping An’s commitment to innovation and openness in the healthcare sector. By integrating globally leading cutting-edge technologies and quality management systems with the realities of China’s medical landscape, Ping An Haoyi Medical Laboratory aims to establish industry standards for medical testing across China, thereby driving high-quality, rapid development of the domestic medical testing industry.

Hao Deming, Vice President and Secretary-General of the Chinese Non-Public Medical Institutions Association

Ping An Haoyi Medical Laboratory fully leverages its joint venture advantages by introducing advanced technologies, highly automated assembly lines, and a meticulous quality control management system. In the future, it will offer over 4,000 medical testing items, maintaining an overall error rate of 3.1 per 10 million. It aims to establish a “1-hour TAT (Turnaround Time) service” model, setting new benchmarks in volume, quality, and timeliness that surpass the current industry standards in China. This initiative will inject new vitality into the domestic medical testing sector and lead the industry toward high-quality, high-standard development.

On-site Plaque-Awarding Group Photo

As a world-leading medical testing service provider, SRL Corporation operates 30 medical testing laboratories across Japan, covering more than 80% of medical institutions nationwide. It processes up to 400 million samples annually and assists over 200 medical institutions in Japan each year with laboratory construction.

Guangzhou Testing Center leverages SRL’s extensive experience, aiming to integrate the strengths of both China and Japan through cutting-edge technology, premium products, and top-tier talent. It is committed to providing Chinese customers with innovative healthcare models and the highest-quality laboratory testing services, with the aspiration of establishing Ping An Haoyi Medical Laboratory as a benchmark for innovative medical development.

Actual Photo of the Guangzhou Testing Center Laboratory

As healthcare system reforms deepen and national policies provide support, the third-party medical testing industry is ushering in unprecedented opportunities. Ping An Haoyi Medical Laboratory has introduced an excellent technical team from Japan, established standardized operating procedures, and formulated a comprehensive quality management system. It provides technical guidance for the development of its affiliated laboratories, implementing unified management, unified processes, and unified standards. This approach facilitates the rapid, high-quality, and high-standard deployment of medical testing laboratories across China, delivering reliable and efficient testing services to primary healthcare institutions in various regions. By providing robust support for primary care, it helps safeguard the health of the nation.